ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,260Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 1844

$641K Total Retail Price of All Prescriptions

Rank: 188 out of 1844

547 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
OMEPRAZOLE 744 400 1 5
SIMVASTATIN 715 409 2 3
LEVOTHYROXINE SODIUM 660 438 3 1
HYDROCHLOROTHIAZIDE 602 502 4 9
FUROSEMIDE 383 238 5 7
LISINOPRIL 348 244 6 4
ENALAPRIL MALEATE 321 221 7 69
METFORMIN HCL 313 182 8 8
HYDROCODONE-ACETAMINOPHEN 312 210 S3 9 2
POTASSIUM CHLORIDE 256 163 10 16
ATENOLOL 249 212 11 17
METOPROLOL TARTRATE 226 164 12 11
RANITIDINE HCL 189 72 13 38
POLYETHYLENE GLYCOL 3350 181 74 14 39
WARFARIN SODIUM 168 163 15 13
ALENDRONATE SODIUM 164 120 16 25
SERTRALINE HCL 157 117 17 21
MELOXICAM 152 101 18 28
ATORVASTATIN CALCIUM 152 97 18 12
AMLODIPINE BESYLATE 149 126 20 6
ZOLPIDEM TARTRATE 145 91 21 23
METOPROLOL SUCCINATE 144 107 22 14
TAMSULOSIN HCL 141 104 23 27
TERAZOSIN HCL 133 58 24 136
CRESTOR 133 68 24 30
GABAPENTIN 124 62 26 15
OXYCODONE-ACETAMINOPHEN 115 68 S2 27 94
CARVEDILOL 114 81 28 22
LOVASTATIN 106 70 29 44
PRAVASTATIN SODIUM 105 72 30 10
GLIPIZIDE 94 38 31 70
NAPROXEN 94 39 31 87
NEXIUM 91 46 33 31
SULINDAC 90 54 34 271
TRAMADOL HCL 89 40 35 18
ETODOLAC 87 75 36 178
TRIAMCINOLONE ACETONIDE 86 31 37 153
KLOR-CON M20 85 58 38 54
GLYBURIDE 84 84 R 39 100
ENALAPRIL-HYDROCHLOROTHIAZIDE 82 52 40 293
CITALOPRAM HBR 81 32 41 19
CYMBALTA 81 49 41 36
DONEPEZIL HCL 80 58 43 26
PHENYTOIN SODIUM EXTENDED 79 34 44 147
SYMBICORT 77 41 45 134
PREDNISONE 76 52 46 40
LANTUS 73 49 47 42
CYCLOBENZAPRINE HCL 72 41 R 48 53
FENOFIBRATE 71 30 49 71
LOSARTAN POTASSIUM 71 63 49 24
CIPROFLOXACIN HCL 66 50 51 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 46 51 73
AMITRIPTYLINE HCL 62 32 R 53 72
SPIRONOLACTONE 61 28 54 60
IBUPROFEN 60 30 55 89
PANTOPRAZOLE SODIUM 59 45 56 32
ALPRAZOLAM 58 58 57 124
LANTUS SOLOSTAR 58 38 57 97
COMBIVENT 56 52 59 131
DOXYCYCLINE HYCLATE 55 32 60 90
GLIPIZIDE ER 54 54 61 79
VYTORIN 54 31 61 211
OXYCODONE HCL-ACETAMINOPHEN 54 34 S2 61 83
FLUTICASONE PROPIONATE 54 28 61 50
FAMOTIDINE 53 29 65 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.